Mitchell J. Bartlett

737 total citations
35 papers, 524 citations indexed

About

Mitchell J. Bartlett is a scholar working on Cellular and Molecular Neuroscience, Neurology and Pharmacology. According to data from OpenAlex, Mitchell J. Bartlett has authored 35 papers receiving a total of 524 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Cellular and Molecular Neuroscience, 7 papers in Neurology and 5 papers in Pharmacology. Recurrent topics in Mitchell J. Bartlett's work include Neuroscience and Neuropharmacology Research (12 papers), Neuropeptides and Animal Physiology (8 papers) and Parkinson's Disease Mechanisms and Treatments (5 papers). Mitchell J. Bartlett is often cited by papers focused on Neuroscience and Neuropharmacology Research (12 papers), Neuropeptides and Animal Physiology (8 papers) and Parkinson's Disease Mechanisms and Treatments (5 papers). Mitchell J. Bartlett collaborates with scholars based in United States, United Kingdom and Belgium. Mitchell J. Bartlett's co-authors include Torsten Falk, Scott J. Sherman, Roger Smith, Michael L. Heien, R.G.G. Russell, Tim Cundy, G. T. Warner, G Heynen, Stephen L. Cowen and Robin Polt and has published in prestigious journals such as Circulation, Brain and Brain Research.

In The Last Decade

Mitchell J. Bartlett

34 papers receiving 491 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mitchell J. Bartlett United States 14 195 100 97 75 69 35 524
Ramazan Kozan Türkiye 13 243 1.2× 77 0.8× 183 1.9× 28 0.4× 34 0.5× 48 524
Francisco Fernández Spain 18 124 0.6× 154 1.5× 48 0.5× 37 0.5× 210 3.0× 39 695
Nuzhath F. Tajuddin United States 19 179 0.9× 189 1.9× 91 0.9× 39 0.5× 96 1.4× 31 883
Kiichiro Taga Japan 16 196 1.0× 153 1.5× 104 1.1× 30 0.4× 76 1.1× 41 1.0k
Flávia Mahatma Schneider Soares Brazil 11 127 0.7× 138 1.4× 118 1.2× 38 0.5× 60 0.9× 12 458
Sen-yang Lang China 17 119 0.6× 87 0.9× 61 0.6× 56 0.7× 65 0.9× 39 681
Yichao Jin China 15 54 0.3× 182 1.8× 212 2.2× 61 0.8× 81 1.2× 39 557
Antonio Martínez‐Salio Spain 14 110 0.6× 139 1.4× 197 2.0× 84 1.1× 61 0.9× 36 784
Anat Milman Israel 13 153 0.8× 300 3.0× 317 3.3× 38 0.5× 53 0.8× 34 901

Countries citing papers authored by Mitchell J. Bartlett

Since Specialization
Citations

This map shows the geographic impact of Mitchell J. Bartlett's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mitchell J. Bartlett with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mitchell J. Bartlett more than expected).

Fields of papers citing papers by Mitchell J. Bartlett

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mitchell J. Bartlett. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mitchell J. Bartlett. The network helps show where Mitchell J. Bartlett may publish in the future.

Co-authorship network of co-authors of Mitchell J. Bartlett

This figure shows the co-authorship network connecting the top 25 collaborators of Mitchell J. Bartlett. A scholar is included among the top collaborators of Mitchell J. Bartlett based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mitchell J. Bartlett. Mitchell J. Bartlett is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bartlett, Mitchell J., Michael L. Heien, Kristian P. Doyle, et al.. (2024). The angiotensin (1–7) glycopeptide PNA5 improves cognition in a chronic progressive mouse model of Parkinson's disease through modulation of neuroinflammation. Experimental Neurology. 381. 114926–114926. 1 indexed citations
2.
3.
Szabó, Lajos, Fahad Al‐Obeidi, Mitchell J. Bartlett, et al.. (2023). Structure-Based Design of Glycosylated Oxytocin Analogues with Improved Selectivity and Antinociceptive Activity. ACS Medicinal Chemistry Letters. 14(2). 163–170. 5 indexed citations
4.
Bartlett, Mitchell J., Dong Lu, Michael L. Heien, et al.. (2023). Antagonism of kappa opioid receptors accelerates the development of L-DOPA-induced dyskinesia in a preclinical model of moderate dopamine depletion. Brain Research. 1821. 148613–148613. 4 indexed citations
5.
Bartlett, Mitchell J., et al.. (2023). Automated system for training and assessing reaching and grasping behaviors in rodents. Journal of Neuroscience Methods. 401. 109990–109990. 2 indexed citations
6.
Molnár, G, Mitchell J. Bartlett, Lajos Szabó, et al.. (2022). Design and Synthesis of Brain Penetrant Glycopeptide Analogues of PACAP With Neuroprotective Potential for Traumatic Brain Injury and Parkinsonism. PubMed. 1. 14 indexed citations
7.
8.
Bartlett, Mitchell J., et al.. (2021). Evaluation of microglia in a rodent model of Parkinson’s disease primed with L-DOPA after sub-anesthetic ketamine treatment. Neuroscience Letters. 765. 136251–136251. 4 indexed citations
9.
Bartlett, Mitchell J., Lajos Szabó, Kate L. Parent, et al.. (2020). Highly-selective µ-opioid receptor antagonism does not block L-DOPA-induced dyskinesia in a rodent model. BMC Research Notes. 13(1). 149–149. 12 indexed citations
10.
Hay, Meredith, Robin Polt, Michael L. Heien, et al.. (2019). A Novel Angiotensin-(1-7) Glycosylated Mas Receptor Agonist for Treating Vascular Cognitive Impairment and Inflammation-Related Memory Dysfunction. Journal of Pharmacology and Experimental Therapeutics. 369(1). 9–25. 52 indexed citations
11.
12.
Bartlett, Mitchell J., et al.. (2018). Ten-Hour Exposure to Low-Dose Ketamine Enhances Corticostriatal Cross-Frequency Coupling and Hippocampal Broad-Band Gamma Oscillations. Frontiers in Neural Circuits. 12. 61–61. 32 indexed citations
13.
14.
Bartlett, Mitchell J., Kate L. Parent, Nicholas D. Laude, et al.. (2015). Long-term effect of sub-anesthetic ketamine in reducing l -DOPA-induced dyskinesias in a preclinical model. Neuroscience Letters. 612. 121–125. 23 indexed citations
15.
Panchal, Ashish R., Uwe Stolz, Mitchell J. Bartlett, et al.. (2014). The impact of ultra-brief chest compression-only CPR video training on responsiveness, compression rate, and hands-off time interval among bystanders in a shopping mall. Resuscitation. 85(9). 1287–1290. 36 indexed citations
16.
Bartlett, Mitchell J., Nicholas D. Laude, Kate L. Parent, et al.. (2014). Differential effects of the NMDA receptor antagonist MK-801 on dopamine receptor D1- and D2-induced abnormal involuntary movements in a preclinical model. Neuroscience Letters. 564. 48–52. 13 indexed citations
17.
Panchal, Ashish R., Uwe Stolz, Mitchell J. Bartlett, et al.. (2013). Abstract 157: Randomized Controlled Trial of the Impact of Ultra-Brief Chest Compression-Only CPR Video Training on Responsiveness, Compression Rate, and Hands-Off Time Interval Among Bystanders in a Shopping Mall. Circulation. 128. 1 indexed citations
18.
Yue, Xin, Beatriz Caballero, S. Zhang, et al.. (2013). Comparative study of the neurotrophic effects elicited by VEGF-B and GDNF in preclinical in vivo models of Parkinson’s disease. Neuroscience. 258. 385–400. 46 indexed citations
19.
Cundy, Tim, Mitchell J. Bartlett, Roger Smith, et al.. (1978). Is 24,25-dihydroxycholecalciferol a calcium-regulating hormone in man?. BMJ. 1(6124). 1382–1386. 82 indexed citations
20.
Kanis, J. A., Roger Smith, R. J. Walton, & Mitchell J. Bartlett. (1976). Magnesium intoxication during 1-alpha-hydroxycholecalciferol treatment].. BMJ. 2(6040). 878.2–878. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ramazan Kozan Breakdown of academic impact, for papers by Francisco Fernández Breakdown of academic impact, for papers by Nuzhath F. Tajuddin Breakdown of academic impact, for papers by Kiichiro Taga Breakdown of academic impact, for papers by Flávia Mahatma Schneider Soares Breakdown of academic impact, for papers by Sen-yang Lang Breakdown of academic impact, for papers by Yichao Jin Breakdown of academic impact, for papers by Antonio Martínez‐Salio Breakdown of academic impact, for papers by Anat Milman
Rankless by CCL
2026